CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Core Laboratories Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$10.15+0.15 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $475.81M
- P/E (TTM)
- 19.5
- Dividend yield
- 0.39%
Core Laboratories Inc. /DE/ revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reservoir Description [Member] | $341.18M | $348.72M | $347.68M | $342.19M | $342.81M | $342.81M | $346.15M | $343.98M | $340.29M | $337.39M | $333.35M | $326.84M | 65.7% | -0.5% |
| Production Enhancement [Member] | $178.00M | $176.02M | $178.84M | $175.31M | $174.57M | $174.99M | $177.70M | $178.84M | $173.48M | $173.68M | $176.45M | $182.31M | 34.3% | +2.0% |
| Corporate and Other [Member] | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reservoir Description [Member] | $34.22M | $42.75M | $43.94M | $47.76M | $47.67M | $46.91M | $51.47M | $47.08M | $43.59M | $45.46M | $41.04M | $35.60M | -28.2% |
| Production Enhancement [Member] | $13.44M | $11.36M | $12.06M | $6.43M | $5.29M | $6.54M | $6.61M | $11.40M | $9.72M | $10.81M | $12.52M | $18.23M | +154.2% |
| Corporate and Other [Member] | $141.00K | -$164.00K | $474.00K | $618.00K | $727.00K | $951.00K | $478.00K | $478.00K | $530.00K | $458.00K | $1.08M | $1.85M | -80.6% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service [Member] | $396.64M | $398.58M | $399.42M | $388.97M | $386.68M | $386.80M | $388.21M | $386.36M | $380.41M | $377.33M | $371.91M | $366.16M | 76.4% | +2.6% |
| Product [Member] | $122.54M | $126.15M | $127.10M | $128.54M | $130.70M | $131.00M | $135.64M | $136.46M | $133.36M | $133.74M | $137.88M | $142.99M | 23.6% | -6.2% |
By region
From the segment and revenue-disaggregation notes of Core Laboratories's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.